SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015389
Filing Date
2017-08-03
Accepted
2017-08-03 16:31:15
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20170630.htm 10-Q 1533487
2 EX-31.1 abio-ex311_8.htm EX-31.1 8578
3 EX-31.2 abio-ex312_6.htm EX-31.2 8536
4 EX-32.1 abio-ex321_7.htm EX-32.1 11183
  Complete submission text file 0001564590-17-015389.txt   5099970

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20170630.xml EX-101.INS 1087827
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20170630.xsd EX-101.SCH 37787
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20170630_cal.xml EX-101.CAL 34317
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20170630_def.xml EX-101.DEF 99120
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20170630_lab.xml EX-101.LAB 296517
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20170630_pre.xml EX-101.PRE 218959
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 171005412
SIC: 2835 In Vitro & In Vivo Diagnostic Substances